Novartis AG (NYSE:NVS) Enters Agreement to Acquire Cadent Therapeutics for $770 Million
Novartis AG (NYSE:NVS) has signed a definitive agreement to acquire all outstanding capital stock of US-based neurosciences firm Cadent Therapeutics
Read more
Jodie Morrison